On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars: What’s the difference between a reference biologic drug […]

Updated March 20201 Having to change any kind of medication can be very stressful. While CDHF believes in patient-physician choice, we acknowledge political policy decisions and […]

Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.